Feedback / Questions
Elayta (CT1812) - Cognition Therap
https://www.globenewswire.com/news-release/2023/07/11/2702523/0/en/Cognition-Therapeutics-Announces-Dosing-of-First-Patient-in-MAGNIFY-Study-of-Oral-CT1812-for-Geographic-Atrophy-Secondary-to-Dry-AMD.html
Jul 11, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next